CollPlant Biotechnologies Ltd.
CLGN
$2.29
-$0.1295-5.35%
NASDAQ
| 12/31/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 11.91M | 18.92M | 23.23M | 26.67M | |
| Total Receivables | 583.00K | 740.00K | 369.00K | 393.00K | |
| Inventory | 440.00K | 439.00K | 645.00K | 714.00K | |
| Prepaid Expenses | -- | -- | -- | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | 248.00K | 236.00K | 239.00K | 241.00K | |
| Total Current Assets | 13.18M | 20.34M | 24.48M | 28.02M | |
|
|
|||||
| Total Current Assets | 13.18M | 20.34M | 24.48M | 28.02M | |
| Net Property, Plant & Equipment | 5.28M | 5.96M | 5.59M | 5.86M | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | 131.00K | 159.00K | 173.00K | 188.00K | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | 118.00K | 113.00K | 57.00K | 57.00K | |
| Total Assets | 18.71M | 26.57M | 30.29M | 34.13M | |
|
|
|||||
| Total Accounts Payable | 870.00K | 1.14M | 1.12M | 980.00K | |
| Total Accrued Expenses | 1.29M | 1.31M | 1.71M | 1.65M | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | 806.00K | 789.00K | 598.00K | 624.00K | |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | |
| Total Other Current Liabilities | -- | -- | -- | -- | |
| Total Current Liabilities | 2.97M | 3.24M | 3.43M | 3.25M | |
|
|
|||||
| Total Current Liabilities | 2.97M | 3.24M | 3.43M | 3.25M | |
| Long-Term Debt | -- | -- | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | 2.28M | 2.60M | 2.42M | 2.54M | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | -- | -- | -- | -- | |
| Total Liabilities | 5.25M | 5.84M | 5.85M | 5.79M | |
|
|
|||||
| Common Stock & APIC | 127.78M | 126.84M | 126.35M | 126.05M | |
| Retained Earnings | -113.35M | -105.15M | -100.94M | -96.74M | |
| Treasury Stock & Other | -969.00K | -969.00K | -969.00K | -969.00K | |
| Total Common Equity | 13.47M | 20.73M | 24.45M | 28.34M | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | -- | -- | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | |
|
|
|||||
| Total Common Equity | 13.47M | 20.73M | 24.45M | 28.34M | |
| Total Preferred Equity | -- | -- | -- | -- | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | 13.47M | 20.73M | 24.45M | 28.34M | |
|
|
|||||